As of August 28, 2026, Cytek Biosciences, Inc. (CTKB) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Cytek Biosciences, Inc. has a market capitalization of $541.11M, 129.98M shares outstanding, 166 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CTKB.
Market Data
Market Cap$541.11M
Shares Outstanding129.98M
Float96.62M
Cash$73.85M
Debt$27.48M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 16.1% shares (2026Q1 vs prior)
166 institutional holders · 96.28M shares
#1
BlackRock, Inc.
17.01M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
9.53M shares
#3
Topline Capital Management, LLC
7.06M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest4.90M
Days to Cover7.5
% of Float5.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track CTKB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CTKB — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CTKB
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.